Tin tức & Cập nhật

Pamrevlumab of little benefit in idiopathic pulmonary fibrosis

31 May 2024

The monoclonal antibody pamrevlumab does not appear to improve outcomes for patients with idiopathic pulmonary fibrosis when compared with placebo, according to the phase III ZEPHYRUS-1 trial.

Pamrevlumab of little benefit in idiopathic pulmonary fibrosis

31 May 2024

SABR hits efficacy, safety targets for NSCLC with interstitial lung disease

29 May 2024

In the treatment of patients with interstitial lung disease (ILD) and early-stage non–small cell lung cancer (NSCLC), stereotactic ablative radiotherapy (SABR) has met the prespecified acceptability thresholds for both toxicity and efficacy, according to the single-arm, phase II ASPIRE-ILD study.

SABR hits efficacy, safety targets for NSCLC with interstitial lung disease

29 May 2024

Bisoprolol does not prevent COPD flare-ups

24 May 2024

The use of bisoprolol does not appear to yield reductions in the number of self-reported chronic obstructive pulmonary disease (COPD) exacerbations requiring treatment with oral corticosteroids, antibiotics, or both, as shown in the placebo-controlled Bisoprolol in COPD Study (BICS).

Bisoprolol does not prevent COPD flare-ups

24 May 2024

Limit intake of ultra-processed food to prolong life: study

24 May 2024 bởi

Individuals who regularly eat ultra-processed foods are at greater risk of death, which is driven by causes other than cancer and cardiovascular diseases (CVD), reports a study.

Limit intake of ultra-processed food to prolong life: study

24 May 2024

COPD associated with elevated risk of secondary spontaneous pneumothorax

23 May 2024

Patients with chronic obstructive pulmonary disease (COPD) face an increased risk of secondary spontaneous pneumothorax, as reported in a study from Taiwan.

COPD associated with elevated risk of secondary spontaneous pneumothorax

23 May 2024

COVID-19 to endanger public health until 2025, says study

22 May 2024 bởi

Although the COVID-19 pandemic is over, the disease remains a threat as it is predicted to become a significant danger to public health in the next 2 years, particularly in the US, according to a study. Wide-ranging vaccination, however, can counter this potential problem.

COVID-19 to endanger public health until 2025, says study

22 May 2024

Dupilumab reduces exacerbations in type 2 asthma regardless of ICS dose

22 May 2024 bởi

Treatment with dupilumab significantly reduced the annual rate of severe exacerbations in children with uncontrolled, moderate-to-severe type 2 asthma who were on high- or medium-dose inhaled corticosteroid (ICS), according to a study presented at PAS 2024.

Dupilumab reduces exacerbations in type 2 asthma regardless of ICS dose

22 May 2024

Multiple pregnancies in women with cystic fibrosis tied to preterm births, respiratory deterioration

20 May 2024

For women with cystic fibrosis, multiple pregnancies lead to higher rates of preterm births and faster respiratory decline, according to a retrospective cohort study.

Multiple pregnancies in women with cystic fibrosis tied to preterm births, respiratory deterioration

20 May 2024

Darbepoetin reduces death, BPD risks in preterm infants

20 May 2024 bởi

Infants treated with darbepoetin through 35 weeks’ postmenstrual age (PMA) have a lower risk of death or grade 2‒3 bronchopulmonary dysplasia (BPD) and a reduced duration of exposure to positive airway pressure, reports a study presented at PAS 2024.

Darbepoetin reduces death, BPD risks in preterm infants

20 May 2024

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

19 May 2024

In people with rheumatic and musculoskeletal diseases (RMDs), inactivated COVID-19 vaccines prove safe and effective at lowering the risk of COVID-19–related pneumonia, as shown in a study from China.

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

19 May 2024

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Pamrevlumab of little benefit in idiopathic pulmonary fibrosis

Pamrevlumab of little benefit in idiopathic pulmonary fibrosis

SABR hits efficacy, safety targets for NSCLC with interstitial lung disease

SABR hits efficacy, safety targets for NSCLC with interstitial lung disease

Bisoprolol does not prevent COPD flare-ups

Bisoprolol does not prevent COPD flare-ups

Limit intake of ultra-processed food to prolong life: study

Limit intake of ultra-processed food to prolong life: study

COPD associated with elevated risk of secondary spontaneous pneumothorax

COPD associated with elevated risk of secondary spontaneous pneumothorax

COVID-19 to endanger public health until 2025, says study

COVID-19 to endanger public health until 2025, says study

Dupilumab reduces exacerbations in type 2 asthma regardless of ICS dose

Dupilumab reduces exacerbations in type 2 asthma regardless of ICS dose

Multiple pregnancies in women with cystic fibrosis tied to preterm births, respiratory deterioration

Multiple pregnancies in women with cystic fibrosis tied to preterm births, respiratory deterioration

Darbepoetin reduces death, BPD risks in preterm infants

Darbepoetin reduces death, BPD risks in preterm infants

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs

Inactivated vaccines help minimize COVID-19–associated pneumonia in RMDs